Tokyo, Japan

Akiyoshi Kadoiri


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1994-1999

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Akiyoshi Kadoiri: Innovator in 1,4-Dihydropyridine Derivatives

Introduction

Akiyoshi Kadoiri is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of 1,4-dihydropyridine derivatives. With a total of seven patents to his name, Kadoiri's work has had a notable impact on vasodilating agents.

Latest Patents

Kadoiri's latest patents focus on 1,4-dihydropyridine derivatives and methods of producing these compounds. These derivatives exhibit vasodilating activity based on calcium antagonism and PAF antagonism. The patents disclose optically active 1,4-dihydropyridine derivatives, which are characterized by a specific formula where a chiral center is indicated. This innovative approach has the potential to enhance therapeutic applications in cardiovascular medicine.

Career Highlights

Throughout his career, Akiyoshi Kadoiri has worked with notable companies such as Fujirebio Inc. and Fujirebio Kabushiki Kaisha. His experience in these organizations has allowed him to refine his expertise in chemical research and development. Kadoiri's dedication to innovation is evident in his extensive patent portfolio.

Collaborations

Kadoiri has collaborated with esteemed colleagues, including Hiroshi Ikawa and Yasuko Konagai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Akiyoshi Kadoiri's contributions to the field of chemistry, particularly through his patents on 1,4-dihydropyridine derivatives, highlight his role as a significant innovator. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…